XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2019   3,294,672    
Beginning Balance at Dec. 31, 2019 $ 192,855,681 $ 95,853,477 $ (20,331,890) $ 117,334,094
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   3,850    
Issuance of restricted stock grants   $ 347,424 (347,424)  
Amortization of restricted stock grants 1,786,217   1,786,217  
Issuance of stock grants (in shares)   23,640    
Issuance of stock grants 3,396,359 $ 3,396,359    
Issuance of common stock related to 401k plan match (in shares)   5,316    
Issuance of common stock related to 401k plan match 647,100 $ 647,100    
Shares withheld related to employee tax withholding (in shares)   (1,801)    
Shares withheld related to employee tax withholding (252,968) $ (252,968)    
Forfeiture of restricted stock grants (shares)   (1,225)    
Forfeiture of restricted stock grants   $ (206,347) 206,347  
Repurchase of common stock (shares)   (76,937)    
Repurchase of common stock (9,182,577) $ (9,182,577)    
Net income 1,530,108     1,530,108
Ending balance (shares) at Mar. 31, 2020   3,247,515    
Ending Balance at Mar. 31, 2020 190,779,920 $ 90,602,468 (18,686,750) 118,864,202
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2019 14,178,824      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 4,058,476      
Net subscriptions of consolidated funds (565,998)      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2020 $ 9,554,350      
Beginning balance (shares) at Dec. 31, 2020 3,168,823 3,168,823    
Beginning Balance at Dec. 31, 2020 $ 184,080,753 $ 80,810,946 (14,748,118) 118,017,925
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   52,434    
Issuance of restricted stock grants   $ 8,160,714 (8,160,714)  
Amortization of restricted stock grants 1,397,132   1,397,132  
Issuance of stock grants (in shares)   3,681    
Issuance of stock grants 529,806 $ 529,806    
Issuance of common stock related to 401k plan match (in shares)   154    
Issuance of common stock related to 401k plan match 24,000 $ 24,000    
Shares withheld related to employee tax withholding (in shares)   (1,729)    
Shares withheld related to employee tax withholding (258,088) $ (258,088)    
Forfeiture of restricted stock grants (shares)   (13,200)    
Forfeiture of restricted stock grants   $ (2,070,780) 2,070,780  
Repurchase of common stock (shares)   (12,529)    
Repurchase of common stock (1,893,146) $ (1,893,146)    
Cash dividend paid of $1.00 per share (3,147,890)     (3,147,890)
Net income $ 13,708,511     13,708,511
Ending balance (shares) at Mar. 31, 2021 3,197,634 3,197,634    
Ending Balance at Mar. 31, 2021 $ 194,441,078 $ 85,303,452 $ (19,440,920) $ 128,578,546
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2020 9,372,333      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (554,102)      
Net subscriptions of consolidated funds 738,711      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2021 $ 10,665,146